In a 54-year-old womanwith diabetes mellitus, hearing loss, muscle weakness and hypocalcemia, caused by idiopathic hypoparathyroidism, an A to G transition at the nucleotide position of 3243 (A3243G mutation) was found in the mitochondrial DNAfrom her leukocytes. Clinical features of diabetes mellitus and hearing loss in association with the A3243Gmutation are compatible with a diagnosis of maternally inherited diabetes and deafness (MIDD). Although hypoparathyroidism is rarely seen in MIDD,we consider that hypoparathyroidism in this patient is a possible phenotype caused by the A3243Gmutation of mitochondrial DNA.
Introduction
Recently many reports have suggested that several mitochondrial DNA(mtDNA)mutations cause a subset of diabetes mellitus (1) (2) (3) (4) (5) , since a point mutation of mtDNAat the nucleotide position of 3243 (an A3243G mutation) was identified in a pedigree with maternally inherited diabetes mellitus and deafness (MIDD) (3) (4) (5) . We describe a female patient associated with an A3243Gmutation of mtDNAwho showed idiopathic hypoparathyroidism and muscle weakness in addition to diabetes mellitus and deafness.
Case Report
A 54-year-old female patient was admitted to our hospital on November 25, 1997, complaining of easy fatigability. She had been in good health until she first noticed hearing impairment at 32 years of age, which was slowly exacerbated over the subsequent twenty years, resulting in complete deafness. Although an elevated fasting blood glucose level was noted at the age of 40, she did not receive any treatment before visiting our hospital. She felt easy fatigability only but has never noticed any gait disturbance or muscle weakness in the extremities. She has never experienced any seizures, myoclonus or stroke-like episodes. She has a son and a daughter, both of whomare in good health now. Her mother suddenly died at 73 years of age from an uncertain cause. None of her family members, including parents, elder sister and four brothers have diabetes mellitus, muscle disorders or deafness. On admission, height was 150.5 cm, weight 32.5 kg, blood pressure 110/70 mmHg,and pulse 60 beats per minute, and regular. Neurological examination indicated that her intelligence was normal. There was mild proximal muscular atrophy in her four limbs. Muscle strength was grade 4 on the manual muscle test. Sensitivity to vibration was decreased on bilateral medial malleolus. Deep tendon reflexes were diminished bilaterally. Chvostek's sign and Trousseau's sign were negative. Motor nerve conduction velocity in the mediannerve was normal (54.5 m/sec). There were no findings of pigmentary retinopathy, cataract, blepharoptosis, or ophthalmoplegia. Simple diabetic retinopathy was observed during an ophthalmological examination. Audiometric studies showedcomplete sensorineural hearing loss in both ears. Her electrocardiogram was normal. Brain computed tomography revealed mild cerebral atrophy but no calcification in the basal ganglia. Laboratory data determined upon admission is shown in Table 1 . Fasting blood glucose was 186 mg/dl, and hemoglobin A1Cwas 8.3%. Serumcreatine kinase and lactate were normal. Urinalysis revealed glucosuria. Creatinine clearance was 61.7 ml/min. After informed consent was obtained, a muscle biopsy was performed on her quadriceps femoris. The biopsy specimens showedno specific abnormalities except for mild muscular atrophy, indicated by an irregularity in diameter and the scattered splitting appearance of muscle fibers. No raggedred fibers were observed on the sections stained by the modified Gomori-trichrome method.
Subsequently, an A to G transition at nucleotide position Table 1 . Laboratory Data on Admission 3243 was examined in the mtDNAof the patient and her children after informed consent was obtained. Mitochondrial DNA was extracted from peripheral leukocytes. The relevant region of the mtDNA was amplified by polymerase chain reaction (PCR) using the primers 5'-TCATCTCAACTTAGTATTAT-3/ and 5'-GTTAAGAAGAGGAATGAACC-3'. PCR products were digested with the restriction endonuclease, Apa I, and electrophoresed in 8% polyacrylamide gel. An A to G transition at nucleotide position 3243 was found in 3% of the patient's mtDNA. In her family study (Fig. 1) , her son, age 32, had the A3243G mutation in 2% of the mtDNA, but he had normal glucose tolerance and a normal insulin secretory response on an oral glucose tolerance test. Nomutation was observed in mtDNAin the patient's daughter, age 28. Anendocrinological examination was performed after the patient was treated with insulin and a better metabolic condition was achieved (Table 2 ). Serum C-peptide immunoreactivity (CPR) 6 minutes after 1 mg of glucagon infusion became slightly increased from 1.0 to 2.2 ng/ml. Daily urinary CPR excretion was slightly decreased. Insulin sensitivity was found to be low (154 mg/dl) using the steady-state plasma glucose (SSPG) method (6) . The levels of serum calcium (Ca) and free Ca were low but the level of serum phosphorus was normal. The amount of urinary Ca excretion was moderately decreased. Intact-parathyroid hormone (PTH), a highly sensitive assay of PTHand 1,25-dihydroxy vitamin D3 were low but normal. On the Ellsworth-Howard's test, there was a normal increase in the excretion of cyclic AMP into the urine, but there was no significant change in that of phosphorus following the intravenous administration of 100 units of human PTH. Thyroid and adrenocortical function were normal. Anti-thyroglobulin, anti- thyroid peroxidase and anti-adrenal antibodies were negative.
Discussion
The A3243Gmutation of mtDNAhas been implicated in the clinically distinct disease, mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) (7, 8) . Recent studies suggested that the A3243Gmutation was also associated with maternally inherited diabetes and deafness (MIDD) (3, 5) without any of the MELASsymptoms. The patient in this study had diabetes mellitus and deafness Mitochondrial Diabetes with Hypocalcemia with an A3243G mutation of mtDNA, and the diagnosis of MIDDcould be made. However, additional clinical features of idiopathic hypoparathyroidism and muscle weakness were observed.
Impaired insulin secretion is thought to be the main pathogenic mechanismcontributing to the development of diabetes associated with the A3243G mutation (4, 5, 9, 10). However, insulin resistance has also been proposed as the pathogenesis of diabetes (1 1). The present patient has non-insulin-dependent diabetes mellitus caused by both impaired insulin secretion and sensitivity. Hypoparathyroidism in this patient was characterized by subclinical and asymptomatic hypocalcemia with a low but normal PTHlevel. Elevation of PTHlevel in association with hypocalcemia is generally observed in various pathological conditions such as nutritional Ca deficiency, vitamin D deficiency, chronic renal failure and pseudohypoparathyroidism, except for idiopathic hypoparathyroidism. The relatively low level of PTHin spite of hypocalcemia in this patient indicated impaired function of the parathyroid gland. The low normal 1,25-dihydroxy vitamin D3 value in the patient may be the result of an inappropriately low secretion of PTH. EllsworthHoward's test showed an increased urinary excretion of cyclic AMPand no significant change in the urinary excretion of phosphorus after the administration of humanPTH.Despite these responses to exogenous PTH,the relatively reduced PTHlevel was highly indicative of idiopathic hypoparathyroidism rather than type II pseudohypoparathyroidism. The absence of clinical symptoms including short stature, osteodystrophy or retarded intelligence also support the diagnosis of idiopathic hypoparathyroidism.
It has recently been shown that a Ca2+-sensing receptor gene mutation causes hypocalcemia with a low PTHlevel (12) . However, patients with this Ca2+-sensing receptor gene mutation have hypercalciuria, which was not observed in our patient. It is known that patients with autoimmune polyglandular syndrome have a variety of clinical features, such as idiopathic hypoparathyroidism and diabetes mellitus, in addition to hypoadrenocorticism and hypothyroidism, resulting from the autoimmune mechanism. The present patient had normal adrenocortical and thyroid functions and did not have either of the antibodies for the adrenocortex or thyroid gland. In mitochondrial diseases, brain, muscle and pancreatic beta cells are predominantly affected because functions of these organs are highly dependent on mitochondrial oxidative phosphorylation (13) . The parathyroid gland may also be vulnerable to mutations in mtDNA because its function requires a high energy supply. In fact, idiopathic hypoparathyroidism has been described in another mitochondrial encephalomyopathy, Kearns-Sayre syndrome (14) (15) (16) (17) , as well as in diabetic patients with an A3243G mutation of mtDNA (18, 19 may also be necessary to examine mutations in the mtDNAof individuals with idiopathic hypoparathyroidism, especially those with a family history of the disease and/or with diabetes mellitus or impaired hearing.
